Michael P. Rudolf

1.7k total citations
33 papers, 1.4k citations indexed

About

Michael P. Rudolf is a scholar working on Immunology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Michael P. Rudolf has authored 33 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 12 papers in Epidemiology and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Michael P. Rudolf's work include Monoclonal and Polyclonal Antibodies Research (12 papers), Immunotherapy and Immune Responses (8 papers) and T-cell and B-cell Immunology (7 papers). Michael P. Rudolf is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (12 papers), Immunotherapy and Immune Responses (8 papers) and T-cell and B-cell Immunology (7 papers). Michael P. Rudolf collaborates with scholars based in Switzerland, United States and Austria. Michael P. Rudolf's co-authors include W. Martin Kast, Steven C. Fausch, Diane M. Da Silva, Sanne Weijzen, Sridevi Gottipati, Radhika Vaishnav, Andrei Zlobin, Kalliopi P. Siziopikou, Jon C. Aster and Lucio Miele and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and The Journal of Immunology.

In The Last Decade

Michael P. Rudolf

33 papers receiving 1.3k citations

Peers

Michael P. Rudolf

IMMUN

EPIDE

ONCOL

RNMI

E J Brown United States

H Domdey Germany

Heinz Hoschützky Germany

Jovanka Bestebroer Netherlands

Joëlle E. Gabay United States

Daniela Dörfel Germany

Davin C. Dillon United States

Isabelle Mondor France

George E. Mark United States

B Lund Sweden

E J Brown United States

Michael P. Rudolf

424 ×0.7

974 ×2.2

IMMUN

238 ×0.6

EPIDE

80 ×0.4

ONCOL

254 ×1.5

RNMI

Citations per year, relative to Michael P. Rudolf Michael P. Rudolf (= 1×) peers E J Brown

Countries citing papers authored by Michael P. Rudolf

Since Specialization

Citations

This map shows the geographic impact of Michael P. Rudolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael P. Rudolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael P. Rudolf more than expected).

Fields of papers citing papers by Michael P. Rudolf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael P. Rudolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael P. Rudolf. The network helps show where Michael P. Rudolf may publish in the future.

Co-authorship network of co-authors of Michael P. Rudolf

This figure shows the co-authorship network connecting the top 25 collaborators of Michael P. Rudolf. A scholar is included among the top collaborators of Michael P. Rudolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael P. Rudolf. Michael P. Rudolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Berger, Karin, et al.. (2024). Long-term effects of doping with anabolic steroids during adolescence on physical and mental health. Die Orthopädie. 53(8). 608–616. 7 indexed citations

Lü, Qin, Philippe Eggimann, Charles‐Édouard Luyt, et al.. (2014). Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes. Critical Care. 18(1). R17–R17. 64 indexed citations

Sécher, Thomas, et al.. (2013). The Anti-Pseudomonas aeruginosa Antibody Panobacumab Is Efficacious on Acute Pneumonia in Neutropenic Mice and Has Additive Effects with Meropenem. PLoS ONE. 8(9). e73396–e73396. 36 indexed citations

Lü, Qin, Jean‐Jacques Rouby, Philippe Eggimann, et al.. (2011). Pharmacokinetics and safety of panobacumab: specific adjunctive immunotherapy in critical patients with nosocomial Pseudomonas aeruginosa O11 pneumonia. Journal of Antimicrobial Chemotherapy. 66(5). 1110–1116. 52 indexed citations

Sécher, Thomas, Louis Fauconnier, Agata Szade, et al.. (2011). Anti-Pseudomonas aeruginosa serotype O11 LPS immunoglobulin M monoclonal antibody panobacumab (KBPA101) confers protection in a murine model of acute lung infection. Journal of Antimicrobial Chemotherapy. 66(5). 1100–1109. 42 indexed citations

Tarköy, Markus, et al.. (2009). A comparative characterization of dipentameric (IgM)2 and pentameric IgM species present in preparations of a monoclonal IgM for therapeutic use. Journal of Pharmaceutical and Biomedical Analysis. 51(5). 1084–1090. 7 indexed citations

Velders, Markwin P., et al.. (2003). Molecular Characterization of Melanoma-Derived Antigens. Humana Press eBooks. 61. 31–70. 2 indexed citations

Fausch, Steven C., Diane M. Da Silva, Michael P. Rudolf, & W. Martin Kast. (2002). Human Papillomavirus Virus-Like Particles Do Not Activate Langerhans Cells: A Possible Immune Escape Mechanism Used by Human Papillomaviruses. The Journal of Immunology. 169(6). 3242–3249. 104 indexed citations

Weijzen, Sanne, Paola Rizzo, Radhika Vaishnav, et al.. (2002). Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nature Medicine. 8(9). 979–986. 433 indexed citations

10.

Rudolf, Michael P., Steven C. Fausch, Diane M. Da Silva, & W. Martin Kast. (2001). Human Dendritic Cells Are Activated by Chimeric Human Papillomavirus Type-16 Virus-Like Particles and Induce Epitope-Specific Human T Cell Responses In Vitro. The Journal of Immunology. 166(10). 5917–5924. 133 indexed citations

11.

Silva, Diane M. Da, Gretchen L. Eiben, Steven C. Fausch, et al.. (2001). Cervical cancer vaccines: Emerging concepts and developments. Journal of Cellular Physiology. 186(2). 169–182. 72 indexed citations

12.

Zuercher, Adrian W., Sylvia Miescher, Monique Vogel, et al.. (2000). Oral anti-IgE immunization with epitope-displaying phage. European Journal of Immunology. 30(1). 128–135. 33 indexed citations

13.

Kricek, Franz, et al.. (1999). IgE–Related Peptide Mimotopes. International Archives of Allergy and Immunology. 118(2-4). 222–223. 3 indexed citations

14.

Thurnheer, M. Christine, et al.. (1999). Molecular mimicry of the unidentified antigen of myeloma antibody IgE-ND. European Journal of Immunology. 29(9). 2676–2683. 4 indexed citations

15.

Rudolf, Michael P., John D. Nieland, Markwin P. Velders, et al.. (1999). Induction of HPV16 Capsid Protein-Specific Human T Cell Responses by Virus-Like Particles. Biological Chemistry. 380(3). 335–40. 41 indexed citations

16.

Schmid, Jana Pachlopnik, Martin R. Stämpfli, Michael P. Rudolf, et al.. (1998). Antigen Interaction and Heat Inactivation Expose New Epitopes on Human IgE. International Archives of Allergy and Immunology. 117(4). 231–238. 8 indexed citations

17.

Velders, Markwin P., John D. Nieland, Michael P. Rudolf, et al.. (1998). Identification of Peptides for Immunotherapy of Cancer. It is Still Worth the Effort. Critical Reviews in Immunology. 18(1-2). 7–27. 22 indexed citations

18.

Stadler, Beda M., et al.. (1997). Can Active Immunization Redirect an Anti-IgE Immune Response?. International Archives of Allergy and Immunology. 113(1-3). 216–218. 5 indexed citations

19.

Stadler, Beda M., et al.. (1996). Anti‐IgE in allergic sensitization. Immunology and Cell Biology. 74(2). 195–200. 8 indexed citations

20.

Stadler, B. M., Martin R. Stämpfli, Sylvia Miescher, Michael P. Rudolf, & Monique Vogel. (1995). Cloning of Human Anti-lgE Autoantibodies and Their Role in the Regulation of IgE Synthesis. International Archives of Allergy and Immunology. 107(1-3). 48–50. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact